A pilot, open-label safety study of quetiapine for treatment of moderate psychotic agitation in the emergency setting

Journal of Psychiatric Practice

Volumn 12, Issue 4, 2006, Pages 223-228

  Currier, Glenn W ^a   Trenton, Adam J ^a   Walsh, Patrick G ^a   Van Wijngaarden, Edwin ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Agitation; Antipsychotic; Emergency setting; Orthostatic hypotension; Quetiapine

Indexed keywords

QUETIAPINE;

ADULT; AGITATION; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; EMERGENCY MEDICINE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; MENTAL PATIENT; OPEN STUDY; ORTHOSTATIC HYPOTENSION; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEDATION; SINGLE BLIND PROCEDURE; TACHYCARDIA; TREATMENT OUTCOME; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; COMORBIDITY; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; EMERGENCY MEDICAL SERVICES; FEMALE; HOSPITALIZATION; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; MIDDLE AGED; PILOT PROJECTS; PSYCHOMOTOR AGITATION; PSYCHOTIC DISORDERS; TIME FACTORS;

EID: 33746821535     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/00131746-200607000-00004     Document Type: Article

References (22)

1. Lehman AF, Lieberman JA, Dixon LB, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 2004;161(2 Suppl):1-56.
2. Kane JM, Leucht S, Carpenter D, et al. The expert consensus guideline series: Optimizing pharmacologic treatment of psychotic disorders. J Clin Psychiatry 2003;64(Suppl 12):1-97.
3. Currier G. Use of atypical antipsychotics in the emergency setting. J Clin Psychiatry 2000;61(suppl 14):21-6.
4. Currier G, Simpson G. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. J Clin Psychiatry. 2001;62:153-7.
5. Currier GW, Chou JCY, Feifel D, et al. Acute treatment of psychotic agitation: A randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. J Clin Psychiatry 2004;65:386-94.
6. Baker B, Kinon BJ, Maguire GA, et al. Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation. J Clin Psychopharmacol 2003;23:342-8.
7. Allen MH, Currier GW, Carpenter D, et al. The expert consensus guideline series: Treatment of behavioral emergencies 2005. J Psychiatr Pract 2005;11(suppl 1):1-108.
8. Allen MH, Carpenter D, Sheets JL, et al. What do consumers say they want and need during a psychiatric emergency? J Psychiatr Pract 2003;9:39-58.
9. Chengappa KNR, Goldstein JM, Greenwood M, et al. A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia. Clin Ther 2003;25:530-41.
10. Arango C, Bernardo M. The effect of quetiapine on aggression and hostility in patients with schizophrenia. Hum Psychopharmacol 2005;20:237-41.
11. Ereshefsky L. Pharmacokinetics and drug interactions: Update for new antipsychotics. J Clin Psychiatry 1996;57(suppl 11):12-25.
12. Seroquel package insert, Physicians' Desk Reference. Montvale, NJ: Thompson PDR; 2006:691-5.
13. Cutler AJ, Goldstein JM, Tumas JA. Dosing and switching strategies for quetiapine fumarate. Clin Ther 2002;24:209-22.
14. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76.
15. Daniel DG, Potkin SG, Reeves KR, et al. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: A double blind, randomized trial. Psychopharmacology (Berl) 2001; 155:128-34.
16. Swift RH, Harrigan EP, Cappelleri JC, et al. Validation of the behavioural activity rating scale (BARS): A novel measure of activity in agitated patients. J Psychiatr Res 2002;36:87-95.
17. Walker GA. Common statistical methods for clinical research: With SAS examples, second edition. Cary, NC: SAS Institute; 2002.
18. Brook S. Intramuscular ziprasidone: Moving beyond the conventional in the treatment of acute agitation in schizophrenia. J Clin Psychiatry 2003;64(Suppl 19):13-8.
19. Preval H, Klotz SG, Southard R, et al. Rapid-acting IM ziprasidone in a psychiatric emergency service: A naturalistic study. Gen Hosp Psychiatry 2005;27:140-4.
20. Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia: A high and low dose double blind comparison with placebo. Arch Gen Psychiatry 1997;54:549-57.
21. Smith MA, McCoy R, Hamer-Maansson et al. Rapid dose escalation with quetiapine: A pilot study. J Clin Psychopharmacol 2005;25:331-5
22. Schillerstrom TL, Schillerstrom JE, Taylor SE. Laboratory findings in emergently medicated psychiatry patients. Gen Hosp Psychiatry 2004;26:411-4.